by Mark Chiang

马克·蒋

Share To

分享到

Researchers have identified a potential method to alleviate certain challenges associated with autism spectrum disorder through noninvasive brain stimulation. A study conducted by a team that includes scientists from the University of Tokyo suggests that transcranial magnetic stimulation (TMS), a technique already employed in treating mood disorders, may improve cognitive adaptability and reduce behaviors linked to difficulties in social interaction, mental flexibility, and visual perception.

研究人员已经确定了一种通过非侵入性脑刺激来缓解与自闭症谱系障碍相关某些挑战的潜在方法。由包括东京大学科学家在内的团队进行的一项研究表明，经颅磁刺激（TMS）这项已被用于治疗情绪障碍的技术，可能提高认知灵活性，并减少与社交互动、心理灵活性和视觉感知困难相关的行为。

The findings indicate that stimulating nerve cells during moments when the brain becomes “stuck” in specific states could enhance flexibility and mitigate some autistic traits..

研究结果表明，在大脑陷入特定状态时刺激神经细胞，可以增强灵活性并减轻某些自闭症特征。

The research explored the application of TMS in a novel way, targeting neural activity patterns associated with rigidity in cognitive processes. TMS involves using magnetic fields to stimulate nerve cells in the brain, and while it has been widely used for mood-related conditions, this study marks its potential extension into addressing autism-related challenges.

该研究以一种新颖的方式探索了TMS的应用，针对与认知过程僵化相关的神经活动模式。TMS涉及使用磁场刺激大脑中的神经细胞，虽然它已被广泛用于情绪相关病症，但这项研究标志着其在应对自闭症相关挑战方面的潜在扩展。

The researchers focused on how this approach could help individuals adapt more effectively to changing situations or stimuli, which are often areas of difficulty for those on the autism spectrum. Further investigation is required to fully understand its efficacy and long-term impact..

研究人员重点关注了这种方法如何帮助个体更有效地适应不断变化的情境或刺激，这通常是自闭症谱系个体的困难领域。要全面了解其效果和长期影响，还需要进一步的研究。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

Date: June 9, 2025

日期：2025年6月9日

Related posts:

相关文章：

Biosimilar Developers Advised to Build Relationships and Prepare Thoroughly for Regulatory Agency Interactions

生物仿制药开发商被建议建立关系并为与监管机构的互动做好充分准备。

Eli Lilly Announces Associate Territory Manager Opening for Cardiometabolic Health in Washington, D.C.

礼来公司宣布在华盛顿特区开设心血管代谢健康领域的副区域经理职位。

Marken Delivers Gene Therapies to Japan with -80°C Temperature Control Over 80-Hour Transit

马克恩以-80°C温控将基因疗法运送到日本，运输时长80小时。

Alvotech and Dr. Reddy’s Partner to Develop Biosimilar of Merck’s Keytruda for Global Cancer Treatment

Alvotech与Dr. Reddy's合作开发默克Keytruda的生物类似药，用于全球癌症治疗

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 版权所有。与我们合作：

[email protected]

电子邮件地址

Author

作者

Mark Chiang

马克·江

Related Post

相关内容

News Flash

新闻快讯

Study Finds Cancer Screening Guidelines Take Over 13 Years to Influence Clinical Practices

研究发现，癌症筛查指南需要13年以上才能影响临床实践

2025-06-20

2025年6月20日